Exact Sciences Corp (EXAS)

143.58 -10.35  -6.72% NASDAQ Jan 26, 13:19 USD
View Full Chart
Price Chart
View All EXAS News

News

View All Events

Events

Date Type Description
02/11/2021 Earnings Exact Sciences Corp Fourth Quarter Earnings for 2020 Release
02/11/2021 17:00 EST Misc Exact Sciences Corp Fourth Quarter Earnings Conference Call for 2020
10/29/2020 17:00 EDT Misc Exact Sciences Corp Third Quarter Earnings Conference Call for 2020
10/29/2020 Earnings Exact Sciences Corp Third Quarter Earnings Result for 2020
07/30/2020 17:00 EDT Misc Exact Sciences Corp Second Quarter Earnings Conference Call for 2020
07/30/2020 Earnings Exact Sciences Corp Second Quarter Earnings Result for 2020
07/23/2020 11:00 EDT Misc Exact Sciences Corp Annual General Meeting for 2019
05/06/2020 17:00 EDT Misc Exact Sciences Corp First Quarter Earnings Conference Call for 2020
05/06/2020 Earnings Exact Sciences Corp First Quarter Earnings Result for 2020
02/21/2020 Misc Exact Sciences Corp Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.exactsciences.com
  • Investor Relations URL: http://investor.exactsciences.com/investor-relations/default.aspx
  • HQ State/Province: Wisconsin
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Feb. 11, 2021
  • Last Earnings Release: Oct. 29, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in liquid biopsy (blood-based) cancer screening.

Top Fund Holders

Symbol Name Weighting
BBH VanEck Vectors Biotech ETF 4.62%
DFRIX Delaware Smid Cap Growth R 3.99%
ARKG ARK Genomic Revolution ETF 3.58%
GOFFX Invesco Global Opp R5 3.39%
FBT First Trust NYSE Arca Biotech ETF 3.34%
ETCGX Eventide Gilead C 2.96%
APDMX Artisan Mid Cap Advisor 2.41%
TRUZX T. Rowe Price New Horizons Z 2.07%
HGOFX Hartford Growth Opportunities F 1.79%
FXH First Trust Health Care AlphaDEX® ETF 1.70%
ARKK ARK Innovation ETF 1.62%
XBI SPDR® S&P Biotech ETF 0.97%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.